鹿山新材(603051.SH):目前背接觸光伏組件(BC電池)封裝膠膜已在測試認證與導入階段
格隆匯10月9日丨鹿山新材(603051.SH)接受特定對象調研時表示,公司一直非常重視新產品研發,提前佈局新的技術與產品,不斷優化和迭代太陽能電池封裝膠膜的產品結構。公司在《招股説明書》中披露了公司募集資金投入項目之一:研發中心建設項目,其研發項目之一為背接觸光伏組件(BC電池)封裝膠膜。該項目主要是為背接觸電池(BC電池)封裝所做的技術研發,重點解決封裝膠膜在超薄厚度下的尺寸穩定性,以及在BC電池量產過程中的其他封裝問題。公司與太陽能組件客户一直保持良好的研發合作,目前該產品已在測試認證與導入階段。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.